Eli Lilly and Company (NYSE:LLY) Trading Down 4.2% on Analyst Downgrade
Eli Lilly and Company (NYSE:LLY – Get Free Report) traded down 4.2% during mid-day trading on Wednesday after Morgan Stanley lowered their price target on the stock from $1,146.00 to $1,124.00. Morgan Stanley currently has an overweight rating on the stock. Eli Lilly and Company traded as low as $689.00 and last traded at $695.88. […]
